Other candidates for the role of serum biomarkers predictive of impending clinical T1D include osteopontin (OPN), a cytokine-like phosphoprotein involved in many physiological and pathological processes, including autoimmunity and potentially even immune processes that occur early before disease onset. This evidence concerns the gene SPP1 and Autoimmunity.